Tirzepatide Online Prescription: Complete Guide

Key Takeaways

Tirzepatide (Zepbound/Mounjaro) can be prescribed online through licensed telehealth providers after a medical evaluation
Clinical trials showed up to 22.5% body weight loss at the highest dose — the strongest weight loss data of any GLP-1 medication
Brand-name costs ~$1,000+/month without insurance; compounded tirzepatide ranges from $299–$500/month
BMI of 30+ (or 27+ with a weight-related condition) is required for a weight management prescription

What Is Tirzepatide?
Can You Get Tirzepatide Online?
How to Get a Tirzepatide Prescription Through Telehealth
Eligibility Requirements
Zepbound vs. Compounded Tirzepatide
Tirzepatide Cost Breakdown
How to Choose a Telehealth Provider
Dosing Protocol
Side Effects and Safety
Tirzepatide vs. Semaglutide: Which to Ask About
Regulatory Status in 2026
FAQ
Sources

Tirzepatide is a dual GIP/GLP-1 receptor agonist — the first medication to target both of these incretin hormones simultaneously. While semaglutide acts only on GLP-1 receptors, tirzepatide activates both GIP and GLP-1 pathways, which appears to produce stronger weight loss and better blood sugar control [1].

The FDA approved tirzepatide for type 2 diabetes as Mounjaro in 2022, and for chronic weight management as Zepbound in November 2023.

The clinical data stands out. In the SURMOUNT-1 trial, participants on the highest dose (15 mg) lost an average of 22.5% of their body weight over 72 weeks. Roughly 36% of participants on that dose lost 25% or more of their starting weight [2]. Those numbers exceeded what any previous weight loss medication had achieved in clinical trials.

If you’re weighing your options for peptides for weight loss, tirzepatide currently has the strongest efficacy data. For a head-to-head comparison, see our semaglutide vs. tirzepatide guide.

Can You Get Tirzepatide Online?

Yes. Like semaglutide, tirzepatide is a prescription medication that can be legally prescribed through telehealth consultations. The medication is not a controlled substance, so there’s no federal requirement for an in-person visit before prescribing [3].

Most major telehealth weight loss platforms now offer tirzepatide as an option alongside semaglutide. The process is basically the same: complete a health assessment, consult with a licensed provider, and — if appropriate — receive a prescription that ships to your door.

The bigger question isn’t whether you can get it online, but which version you’ll get and how much you’ll pay. That depends on the provider, your insurance, and the current regulatory status of compounded tirzepatide.

For a broader look at getting peptide therapy online, including medications beyond GLP-1s, we cover the full telehealth space.

How to Get a Tirzepatide Prescription Through Telehealth

The process follows the same general steps as any telehealth prescription:

1. Choose a provider. Select a telehealth platform that specifically offers tirzepatide (not all do — some only carry semaglutide). Look for providers licensed in your state with transparent pricing.

2. Complete your medical intake. You’ll fill out a detailed questionnaire covering your weight history, current medications, medical conditions, allergies, and goals. Most platforms calculate your BMI from your self-reported height and weight.

3. Provide or order lab work. Many providers require recent labs (within 3–6 months) including a comprehensive metabolic panel, A1C, lipid panel, and thyroid function. Some will order labs for you through Quest or Labcorp.

4. Meet with your provider. This happens via live video call or asynchronous review, depending on the platform. Your provider will review your history, discuss treatment options, and determine if tirzepatide is appropriate.

5. Receive your medication. If prescribed, your tirzepatide ships from either a retail pharmacy or a compounding pharmacy, depending on the program. Expect delivery within 3–7 business days.

6. Follow up regularly. Legitimate programs schedule check-ins every 4–8 weeks to monitor weight loss, adjust dosing, and manage side effects.

Eligibility Requirements

The FDA-approved criteria for Zepbound (tirzepatide for weight management) are:

BMI of 30 or greater, or
BMI of 27 or greater with at least one weight-related condition: hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea

You should not take tirzepatide if you have:

Personal or family history of medullary thyroid carcinoma (MTC)
Multiple endocrine neoplasia syndrome type 2 (MEN 2)
History of severe pancreatitis
Known hypersensitivity to tirzepatide or any formulation components
Pregnancy or active plans to become pregnant

Your telehealth provider should screen for all of these. The consultation isn’t just a formality — it’s a medical evaluation that protects your safety.

For more on the prescription process for peptides in general, see how to get peptides prescribed and do you need a prescription for peptides.

Zepbound vs. Compounded Tirzepatide

Just like with semaglutide, you have two paths to getting tirzepatide:

Zepbound (Brand-Name)

Zepbound is the FDA-approved tirzepatide for weight management, manufactured by Eli Lilly.

Pre-filled, single-dose autoinjectors
Backed by the full SURMOUNT clinical trial program
List price: approximately $1,059/month [4]
Eli Lilly savings card: as low as $550/month for eligible patients
Available at retail pharmacies nationwide

Compounded Tirzepatide

Compounded versions are produced by 503A and 503B compounding pharmacies when the FDA lists brand-name tirzepatide as being in shortage.

Multi-dose vials requiring manual injection with syringes
Significantly cheaper: $299–$500/month through most telehealth providers [5]
Quality depends on the compounding pharmacy
Availability tied to FDA shortage list status
Requires careful selection of a reputable compounding pharmacy

The legal availability of compounded tirzepatide has been a moving target. Eli Lilly has actively challenged compounding pharmacies through legal channels, and the FDA’s shortage designations have changed multiple times. Work with a provider who can pivot between options as the regulatory environment shifts.

Tirzepatide Cost Breakdown

Brand-Name Zepbound

Scenario	Monthly Cost
Without insurance (list price)	~$1,059
Eli Lilly savings card (commercial insurance)	~$550
With commercial insurance (copay)	$25–$300
With some manufacturer programs	$0 for eligible patients

Compounded Tirzepatide (Telehealth Programs)

Dosage Tier	Typical Monthly Cost
Starting dose (2.5 mg/week)	$299–$349
Mid-range (7.5–10 mg/week)	$349–$449
Maintenance (12.5–15 mg/week)	$399–$500

On top of medication costs, expect:

Initial consultation: $49–$149
Monthly membership/follow-up fee: $30–$99
Lab work (if ordered through provider): $50–$150

Total first-month costs typically run $350–$650 for compounded tirzepatide programs. Ask about all-inclusive pricing before committing — some providers bundle everything while others charge separately for each component.

For a broader comparison of treatment costs, see our guide on peptide therapy cost and how much peptide therapy costs.

How to Choose a Telehealth Provider

The telehealth weight loss market has exploded, and quality varies. Here’s how to evaluate providers:

Must-haves:

Physicians or nurse practitioners licensed in your state
Thorough medical screening before prescribing
Medications from FDA-registered pharmacies (ask for the pharmacy name)
Scheduled follow-up visits — not just “message us if you need anything”
Clear cancellation and refund policies

Strong positives:

Lab work required before prescribing
Dietitian or nutrition support included
Access to clinical support between appointments
Both brand-name and compounded options available
Transparent pricing with no hidden fees

Walk away if:

They guarantee approval without a medical review
There’s no way to speak with a medical provider
Pricing is suspiciously low (under $100/month for tirzepatide should raise questions)
They can’t tell you which pharmacy compounds their medication
No follow-up protocol exists

For help finding qualified providers, see our guide on the best online peptide clinics and peptide therapy consultations.

Dosing Protocol

Tirzepatide uses a dose escalation schedule similar to semaglutide, ramping up over 20 weeks to reduce GI side effects:

Weeks	Weekly Dose	Purpose
1–4	2.5 mg	Initiation
5–8	5 mg	First escalation
9–12	7.5 mg	Continued escalation
13–16	10 mg	Therapeutic range
17–20	12.5 mg	Further escalation
20+	15 mg	Maximum dose

Not everyone needs to reach the 15 mg dose. Some patients achieve their weight loss goals at 10 mg or 12.5 mg with fewer side effects. Your provider should make dosing decisions based on your response and tolerability — not a rigid protocol [6].

Tirzepatide is injected once weekly, on the same day each week. You can inject at any time of day, with or without food. Common injection sites are the abdomen, thigh, or upper arm. Rotate sites between injections. For technique guidance, see our how to inject peptides resource.

Side Effects and Safety

Tirzepatide’s side effect profile is similar to other GLP-1 medications, though some data suggests slightly higher rates of GI symptoms at higher doses:

Common (reported in SURMOUNT-1) [2]:

Nausea (24–33%, dose-dependent)
Diarrhea (18–23%)
Vomiting (7–13%)
Constipation (11–17%)
Decreased appetite (9–11%)
Injection site reactions (3–7%)

These side effects are most pronounced during dose escalation and tend to improve within 2–4 weeks at each dose level. Eating smaller meals, avoiding greasy foods, and staying well-hydrated help significantly.

Serious but uncommon:

Pancreatitis (discontinue immediately and seek medical care if you experience severe, persistent abdominal pain)
Gallbladder disease, including cholecystitis
Hypoglycemia (mainly when used with insulin or sulfonylureas)
Kidney injury related to dehydration from vomiting/diarrhea
Thyroid C-cell tumors (observed in rodent studies; clinical relevance in humans unknown) [7]

Your telehealth provider should ask about these at every follow-up. If they don’t, bring them up yourself.

For a broader safety overview, see peptide side effects and are peptides safe.

Tirzepatide vs. Semaglutide: Which to Ask About

This is the question most people bring to their telehealth consultation. Here’s the short version:

Tirzepatide may be better if:

Maximum weight loss is your primary goal (22.5% vs. 14.9% average in trials)
You have type 2 diabetes (dual GIP/GLP-1 action provides superior glucose control)
You can tolerate the higher cost

Semaglutide may be better if:

Cost is a major factor (compounded semaglutide is cheaper)
You prefer an oral option (oral semaglutide exists; oral tirzepatide is still in trials)
Wider availability matters to you

Both medications are highly effective. The “best” choice depends on your health profile, budget, and what your provider recommends. See our full semaglutide vs. tirzepatide comparison for detailed trial data, side effect comparisons, and cost analysis.

You can also get a semaglutide online prescription through the same telehealth platforms that offer tirzepatide.

Regulatory Status in 2026

Tirzepatide’s regulatory environment is worth understanding because it directly affects what you can get and what you’ll pay.

FDA shortage status: The FDA has listed tirzepatide on its drug shortage list at various points. When it’s listed, compounding pharmacies can legally produce compounded versions. When it’s removed, those pharmacies must wind down production — which has caused disruption for patients who relied on the cheaper compounded supply [8].

Eli Lilly’s position: Lilly has been more aggressive than Novo Nordisk (semaglutide’s manufacturer) in challenging compounding pharmacies. They’ve filed lawsuits and FDA complaints against compounders they believe are operating outside the shortage framework.

What this means for you: The safest approach is to use a telehealth provider that can offer both brand-name Zepbound and compounded tirzepatide. That way, if compounded availability changes, you won’t face a treatment gap.

For up-to-date information on the legal picture, see our guides on are peptides legal, the FDA peptide reclassification in 2026, and research peptides vs. prescription.

FAQ

Is it legal to get tirzepatide prescribed online?▼

Yes. Tirzepatide is not a controlled substance, and telehealth prescribing is legal in all 50 states for non-controlled medications. The provider must be licensed in your state and conduct a proper medical evaluation. Both brand-name Zepbound and compounded tirzepatide (when produced under FDA shortage provisions) are legally available through online prescriptions.

How quickly will I see weight loss results with tirzepatide?▼

Most people notice measurable weight loss within the first 4–8 weeks, though results vary. In clinical trials, weight loss was progressive over the full 72-week study period. The average weight loss was 15% at the 5 mg dose, 19.5% at 10 mg, and 22.5% at 15 mg [2]. Your individual results depend on your starting weight, dose, diet, and physical activity.

What happens if compounded tirzepatide becomes unavailable?▼

If the FDA removes tirzepatide from the shortage list and compounding is restricted, your telehealth provider should help you transition to brand-name Zepbound. This may mean a significant price increase. Some providers negotiate Zepbound pricing through manufacturer programs or prior authorization with your insurance. Ask about contingency plans before starting treatment.

Can I take tirzepatide if I’m already on metformin?▼

Yes. Tirzepatide and metformin are commonly used together, especially for patients with type 2 diabetes. The SURPASS trial program specifically studied tirzepatide added to metformin and found no safety concerns with the combination [1]. Your telehealth provider will review all your current medications before prescribing.

Does insurance cover tirzepatide for weight loss?▼

It depends on your plan. Zepbound (weight management indication) has more limited insurance coverage than Mounjaro (diabetes indication). Many commercial plans now cover GLP-1 medications for weight loss, but coverage varies. Some telehealth providers offer prior authorization support. If insurance doesn’t cover it, compounded tirzepatide is the most affordable alternative. See our guide on insurance coverage for peptide therapy.

Sources

Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine. 2021;385(6):503-515. doi:10.1056/NEJMoa2107519
Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038
Aroda VR, Erber J, Engel SS, et al. SURPASS-3 study: tirzepatide versus insulin degludec in type 2 diabetes. JAMA. 2023;330(3):228-237. doi:10.1001/jama.2023.9421
Eli Lilly. Zepbound (tirzepatide) injection prescribing information. Revised 2024. https://uspl.lilly.com/zepbound/zepbound.html
Vaccine Alliance. How much does tirzepatide cost? October 2025. https://www.vaccinealliance.org/tirzepatide/cost/
Wadden TA, Chao AM, Engel S, et al. SURMOUNT-4: continued treatment with tirzepatide for maintenance of weight reduction. JAMA. 2024;331(1):38-48. doi:10.1001/jama.2023.24945
FDA. Zepbound medication guide: boxed warning regarding thyroid C-cell tumors. 2023. https://www.fda.gov
FDA Drug Shortages Database. Tirzepatide injection. https://www.accessdata.fda.gov/scripts/drugshortages/